Condition
Epilepsy, Rolandic
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Completed2
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04954729CompletedPrimary
Association of Processing Speed Dysfunction and Brain Functional Abnormality in ECTS
NCT03465566Unknown
Emotion Recognition in Benign Epilepsy of Childhood With Centro-Temporal Spikes (BECTS)
NCT00216567Phase 4CompletedPrimary
Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy
NCT00471744Phase 3TerminatedPrimary
HEAD-Study Optimizing the Treatment of Children With BECTS
Showing all 4 trials